Prostate Cancer Survival Statistics and Results
Learn More About This Topic: Chat with Us | Email Us
How do you decide where to go for treatment after you have been diagnosed with prostate cancer? At Cancer Treatment Centers of America (CTCA), we believe that knowing the prostate cancer survival rates of patients who are treated at our hospitals is one of the things that can help you and your family as you make this decision. Therefore, we asked an independent, third-party biostatistician to analyze the survival results of patients who were treated at CTCA.
The chart below shows the survival results of 61 advanced-stage prostate cancer patients who were diagnosed between 2004 and 2008 and who received treatment at CTCA for the duration of their illness.
Of the group of CTCA patients shown in the above graph, their average survival rate at six months was 93%. This means that six months after their diagnosis, 93% of the patients in this group were still alive.
Prostate cancer survival rates are also meaningful when compared to the results of other treatment centers. Unfortunately, most hospitals and treatment centers don’t make their survival statistics available to the public. When they do, the results are not always consistently presented, so objective comparisons are difficult.
As an alternative, we asked the independent biostatistician to analyze and compare our survival statistics to national cancer survival statistics that are gathered by the National Cancer Institute (NCI). This database is called the NCI Surveillance, Epidemiology and End Results Program, or SEER, for short. The SEER web site can be accessed at seer.cancer.gov or you can learn more at the NCI SEER Program page.
The chart below shows the cancer survival rates of 45 advanced-stage prostate cancer patients who were diagnosed between 2000 and 2005 and who received treatment at CTCA for the duration of their illness.
In the above chart, the patients in both samples had advanced-stage prostate cancer. Because the SEER database did not provide staging information for patients diagnosed in 2004 and 2005, the SEER sample includes only those patients diagnosed between 2000 and 2003.
The green bars represent advanced-stage cancer patient survival rates from CTCA. The blue bars represent advanced-stage patient survival rates from the SEER database.
The differences in survival rates at 6 months are not statistically significant at a 5% level.
The differences at 1 year through 4 years are statistically significant.
As you study the chart, it’s important to remember that the estimated CTCA prostate cancer survival rates were based on a relatively small sample of 45 advanced-stage prostate cancer patients and therefore were subject to a high degree of variation. The CTCA sample is small because only cancer patients who had been treated exclusively at CTCA since their initial diagnosis were included. In addition, the analysis excluded any patient whose medical records had missing information. This, among other factors, means that the estimates reflected in the survival chart may not be replicated in the future when a larger CTCA sample is available for comparison.
We also want to be sure you understand that cancer is a complex disease and each person’s medical condition is different; therefore, CTCA makes no claims about the efficacy of specific treatments or the delivery of care, and not all cancer patients who are treated at a CTCA hospital may experience these same results.
Questions About Our Prostate Cancer Statistics? We’re Here for You
If you have questions about our prostate cancer survival rates or the comparison charts presented on our web site, call our Oncology Information Specialists who are available 24 hours a day, every day of the year, at 1-800-615-3055. You can also Chat Now or explore our prostate cancer treatment program in more detail.
More:
Prostate Cancer Quality of Life
Prostate Cancer Patient Experience
HCAHPS Results
Speed of Care
Prostate Cancer Survivors
